Your browser doesn't support javascript.
loading
Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial.
Kaufmann, Horacio; Vickery, Ross; Wang, Whedy; Kanodia, Jitendra; Shibao, Cyndya A; Norcliffe-Kaufmann, Lucy; Haumann, Brett; Biaggioni, Italo.
Afiliação
  • Kaufmann H; Department of Neurology, Dysautonomia Center, NYU Langone Health, New York University School of Medicine, 530 First Avenue, Suite 9Q, New York, NY, 10016, USA. Horacio.Kaufmann@nyulangone.org.
  • Vickery R; Theravance Biopharma Ireland Limited, Dublin, Ireland.
  • Wang W; Formerly of Theravance Biopharma US, Inc., South San Francisco, CA, USA.
  • Kanodia J; Theravance Biopharma US, Inc., South San Francisco, CA, USA.
  • Shibao CA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Norcliffe-Kaufmann L; Theravance Biopharma US, Inc., South San Francisco, CA, USA.
  • Haumann B; Formerly of Theravance Biopharma UK Limited, London, UK.
  • Biaggioni I; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Clin Auton Res ; 31(6): 699-711, 2021 12.
Article em En | MEDLINE | ID: mdl-34657222
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article